ABSTRACT
Historically, upper abdominal disease has been a barrier to successful cytoreduction. It has been suggested that upper abdominal tumor burden reects biological aggressiveness and precludes long-term survival. Recent published reports demonstrate that extensive upper abdominal resections required to achieve minimal residual disease are associated with extended long-term survival, and thus, operative eorts should not be abbreviated because of metastatic disease present at this anatomic region [1,2].
